- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
U.S. Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20
Results
4
0 new
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIIB | US$140.64 | 2.4% | -37.0% | US$20.6b | US$201.38 | PE12.6x | E7.6% | n/a | ||
UTHR | US$361.10 | -2.6% | 59.1% | US$16.1b | US$404.16 | PE14.5x | E10.0% | n/a | ||
INVA | US$18.08 | 0% | 16.8% | US$1.1b | US$19.00 | PE17.5x | S4.3% | 0% | ||
DMTK.Q | US$0.000001 | 0% | -100.0% | US$35.0 | n/a | PS0.000002x | n/a | n/a |
Page 1 of 1